{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:02:13Z","timestamp":1786737733562,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Kidney Dis Transpl"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/1319-2442.308364","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T08:25:37Z","timestamp":1611908737000},"page":"1427","source":"Crossref","is-referenced-by-count":2,"title":["Meropenem at recommended dose is a potential risk for seizure in hemodialysis patient"],"prefix":"10.4103","volume":"31","author":[{"given":"Abdullah","family":"Al-Hwiesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Alhwiesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IbrahiemSaeed","family":"Abdul-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Al-Harbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dujanah","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Skiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaser","family":"Abdulkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Beheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morwa","family":"Radi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal","family":"AlKhaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeeza","family":"Aldwaihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-2442.308364-1","unstructured":"Shih T. Seizures and Epilepsy in Older Adults: Etiology, Clinical Presentation, and Diagnosis. Top. 2223., Ver. 33.0. UpToDate; 2019."},{"key":"key-10.4103\/1319-2442.308364-2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ana.410270304","article-title":"A survey of epileptic disorders in southwest France: Seizures in elderly patients","author":"Loiseau","year":"1990","journal-title":"Ann Neurol"},{"key":"key-10.4103\/1319-2442.308364-3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0736-4679(01)00474-7","article-title":"Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department","author":"Pesola","year":"2002","journal-title":"J Emerg Med"},{"key":"key-10.4103\/1319-2442.308364-4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/15563650.2014.918627","article-title":"Seizures after single-agent overdose with pharmaceutical drugs: Analysis of cases reported to a poison center","author":"Reichert","year":"2014","journal-title":"ClinToxicol (Phila)"},{"key":"key-10.4103\/1319-2442.308364-5","unstructured":"Meropenem: Drug Information. Top. 9613., Ver. 220.0. UpToDate; 2019."},{"key":"key-10.4103\/1319-2442.308364-6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0002-9343(85)90104-4","article-title":"Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem\/cilastatin","author":"Calandra","year":"1985","journal-title":"Am J Med"},{"key":"key-10.4103\/1319-2442.308364-7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00006454-199102000-00009","article-title":", Ross LA, Mason WH, Inderlied CB, Kim KS.Imipenem\/cilastatin treatment of bacterial meningitis in children","author":"Wong","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.4103\/1319-2442.308364-8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/1319-2442.308364-9","unstructured":"Primaxin. Whitehouse Station, NJ: Merck & Co., Inc.; 2012."},{"key":"key-10.4103\/1319-2442.308364-10","unstructured":"Merrem. Wilmington, DE: Astra Zeneca; 2010."},{"key":"key-10.4103\/1319-2442.308364-11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2165\/00002018-200730080-00002","article-title":"Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem","author":"Linden","year":"2007","journal-title":"Drug Saf"},{"key":"key-10.4103\/1319-2442.308364-12","first-page":"413","article-title":"Antimicrobial resistance among gram-negative organisms in the intensive care unit","author":"Clark","year":"2003","journal-title":"CurrOpinCrit Care"},{"key":"key-10.4103\/1319-2442.308364-13","first-page":"2043","article-title":"The risk of seizures among the carba-penems: A meta-analysis","author":"Cannon","year":"2014","journal-title":"J AntimicrobChemother"},{"key":"key-10.4103\/1319-2442.308364-14","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1128\/AAC.46.11.3506-3511.2002","article-title":"Pharmacokinetics of ertapenem in healthy young volunteers","author":"Majumdar","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/1319-2442.308364-15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijantimicag.2003.11.004","article-title":"Mechanisms of antibiotic neurotoxicity in renal failure","author":"Chow","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/1319-2442.308364-16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jcpt.12239","article-title":"The recommended dose of ertapenem poses a potential risk for central nervoussystem toxicity in hemodialysis patients \u2013 Case reports and literature reviews","author":"Lee","year":"2015","journal-title":"J Clin Pharm Ther"},{"key":"key-10.4103\/1319-2442.308364-17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1592\/phco.31.4.408","article-title":"Epileptogenic potential of carbapenem agents: Mechanism of action, seizure rates, and clinical considerations","author":"Miller","year":"2011","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/1319-2442.308364-18","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/AAC.00427-08","article-title":"Effect of protein binding on the pharmacological activity of highly bound antibiotics","author":"Schmidt","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:58:42Z","timestamp":1786733922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.308364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"alternative-id":["308364"],"URL":"https:\/\/doi.org\/10.4103\/1319-2442.308364","relation":{},"ISSN":["1319-2442"],"issn-type":[{"value":"1319-2442","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}